• Investor Home
  • Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference

Monday, March 5, 2018 3:05 pm CST

Public Company Information:

NASDAQ:
APEN

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton Laguna Niguel in Orange County, CA. The presentation is scheduled for Monday, March 12, 2018 at 11:00 am PT.

Investors attending the conference who would like to schedule a one-on-one meeting with Apollo management may do so by contacting their ROTH Capital Partners representative, or Lee Roth of The Ruth Group at apolloendo@theruthgroup.com.

An audio webcast of the Company’s presentation will be available online at www.apolloendo.com. A replay of the presentation will be available for 90 days.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Apollo’s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 70 countries today.

Apollo’s common stock is traded on Nasdaq Global Market under the symbol "APEN." For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contact:

Apollo Endosurgery, Inc.
Stefanie Cavanaugh, 512-279-5100
Chief Financial Officer
investor-relations@apolloendo.com
or
The Ruth Group
Lee Roth, 646-536-7012
apolloendo@theruthgroup.com

Business Wire InvestorHQ℠